Melanoma experts optimistic about Jimmy Carter’s progress
The former Democratic president, known for his unassuming style, offered a quick smile as people who had come for the Sunday School class he teaches gasped and clapped.
Audio clip: Listen to audio clip.
Former President Jimmy Carter says that his most recent brain scan showed no signs of cancer.
The former President announced in August that a deadly form of skin cancer, melanoma, which was first found in his liver, had spread to his brain.
“When I went this week, they didn’t find any cancer at all, so I have good news”, Mr Carter told the crowd at Maranatha Baptist Church in his hometown of Plains on Sunday, according to a video from NBC News.
During a press conference in August, Carter announced that his melanoma had spread to his liver and brain.
He received radiation targeting the tumors and regular doses of the drug. So Carter may find himself facing cancer once again, even as he continues treatments created to keep the cancer under control, said Turnham, who notes that immune therapies don’t work for everyone.
“My hair is back and I am fat and happy”, she said. So that part of it has been a relief to me and I think to the doctors. Keytruda, which costs $150,000 a year, is one of eight new melanoma drugs approved since 2011, said Timothy Turnham, executive director of the Melanoma Research Foundation. “Once you understand what is going on in the cancer at a biochemical level or a molecular level, you can accelerate and have tremendous progress”. The interaction between the two genes lets some tumors escape detection and destruction by immune system cells.
“For today, the news can not be better”, said Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society.
Chemotherapy can be hard on patients-along with killing cancer cells, it can also kill healthy cells.
I am not cancer-free but I am surviving with it and basically doing well,”she said”. Instead, they may say things like, “The cancer can’t be seen on the scan” or “I see no evidence of any cancer”.
Based on my reading and my personal experience, I can’t imagine that any oncologist would suggest that cancer of a patient under active treatment is gone or has disappeared. Keytruda, which got approved to treat a form of lung cancer in October, is also being explored to treat a number of other cancers, including head and neck cancer, breast cancer, bladder cancer, and Hodgkin Lymphoma.
In an early trial of the Merck & Co. drug pembrolizumab, which influenced its accelerated approval from the US Food and Drug Administration on September 4 of past year, tumor size decreased by 24 percent on average in patients taking the drug.
“There’s always the suspicion there are other small lesions and cancer cells”.